ArticleNature communications2025
Inducible chromosomal rearrangement reveals nonlinear polygenic dosage effects in driving aneuploid yeast traits.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthetic rewriting technologies in mammalian cells.Nature communications · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aneuploidy induces chromosomal scale alterations in gene dosage, impacting organismal proliferation yet serving as a driver for adaptive evolution. The complexity of gene dosage effects makes it challenging to elucidate the causal genetic basis of aneuploid consequence. Here, using loss-of-function screening with Synthetic Chromosome Rearrangement and Modification by LoxP-mediated Evolution (SCRaMbLE) in synthetic aneuploid yeast, in conjunction with gain-of-function testing in euploid yeast, we established a sufficient and necessary framework and discovered cases of nonlinear polygenic dosage effects in driving aneuploid phenotypes. We identified an emergent effect resulting from copy number alterations in a locus of five genes, which enhance trehalose biosynthesis and confer heat tolerance in aneuploid yeast with additional chromosome III. Additionally, a gene dosage-dependent antagonistic epistasis effect of two genes YCL039W and YCL037C determines rapamycin resistance in aneuploid yeast by regulating the Ras signaling pathway. Moreover, several cases of sufficiency-necessity asymmetries were found for other aneuploid traits. Together, our findings provide direct evidence of various dosage-dependent nonlinear polygenic interactions in shaping aneuploid phenotypes and advance understanding of the genetic basis of cellular adaptive evolution.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.